The Ocular Surface and the Coronavirus Disease 2019: Does a Dual 'Ocular Route' Exist?

Pietro Emanuele Napoli, Matteo Nioi, Ernesto d'Aloja, Maurizio Fossarello, Pietro Emanuele Napoli, Matteo Nioi, Ernesto d'Aloja, Maurizio Fossarello

Abstract

Coronavirus disease 2019 (COVID-19) is an important health problem that was defined as a pandemic by the World Health Organization on 11 March 2020. Although great concern has been expressed about COVID-19 infection acquired through ocular transmission, its underlying mechanism has not currently been clarified. In the current work, we analyzed and elucidated the two main elements that should be taken into account to understand the "ocular route", both from a clinical and molecular point of view. They are represented by the dynamism of the ocular surface system (e.g., the tear film turnover) and the distribution of ACE2 receptors and TMPRSS2 protein. Although it seems, at the moment, that there is a low risk of coronavirus spreading through tears, it may survive for a long time or replicate in the conjunctiva, even in absence of conjunctivitis signs, indicating that eye protection (e.g., protective goggles alone or in association with face shield) is advisable to prevent contamination from external droplets and aerosol.

Keywords: ACE-2 receptor; COVID-19; SARS-CoV-2; conjunctivitis; cornea; coronavirus; dual ocular route; eye; ocular surface; transmission.

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Eurosurveillance Editorial Team Note from the editors: World Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern. Eurosurveillance. 2020;25 doi: 10.2807/1560-7917.ES.2020.25.5.200131e.
    1. Napoli P.E., Nioi M. Global Spread of Coronavirus Disease 2019 and Malaria: An Epidemiological Paradox in the Early Stage of A Pandemic. J. Clin. Med. 2020;9:E1138. doi: 10.3390/jcm9041138.
    1. Liu J., Liao X., Qian S., Yuan J., Wang F., Liu Y., Wang Z., Wang F.S., Liu L., Zhang Z. Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China, 2020. Emerg. Infect. Dis. 2020;26 doi: 10.3201/eid2606.200239.
    1. Chen L., Liu M., Zhang Z., Qiao K., Huang T., Chen M., Xin N., Huang Z., Liu L., Zhang G., et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br. J. Ophthalmol. 2020 doi: 10.1136/bjophthalmol-2020-316304.
    1. Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X., Liu L., Shan H., Lei C.L., Hui D.S., et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2002032.
    1. Wu P., Duan F., Luo C., Liu Q., Qu X., Liang L., Wu K. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020 doi: 10.1001/jamaophthalmol.2020.1291.
    1. Colavita F., Lapa D., Carletti F., Lalle E., Bordi L., Marsella P., Nicastri E., Bevilacqua N., Giancola M.L., Corpolongo A., et al. SARS-CoV-2 Isolation From Ocular Secretions of a Patient With COVID-19 in Italy With Prolonged Viral RNA Detection. Ann. Intern. Med. 2020 doi: 10.7326/M20-1176.
    1. Li J.O., Lam D.S.C., Chen Y., Ting D.S.W. Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear. Br. J. Ophthalmol. 2020;104:297–298. doi: 10.1136/bjophthalmol-2020-315994.
    1. Tang X., Wu C., Li X., Song Y., Yao X., Wu X., Duan Y., Zhang H., Wang Y., Qian Z., et al. On the origin and continuing evolution of SARS-CoV-2. Nat. Sci. Rev. 2020:nwaa036. doi: 10.1093/nsr/nwaa036.
    1. Hoffmann M., Kleine-Weber H., Schroeder S., Krüger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically-proven protease inhibitor. Cell. 2020 doi: 10.1016/j.cell.2020.02.052.
    1. Fodoulian L., Tuberosa J., Rossier D., Landis B.N., Carleton A., Rodriguez I. SARS-CoV-2 receptor and entry genes are expressed by sustentacular cells in the human olfactory neuroepithelium. BioRxiv. 2020 doi: 10.1101/2020.03.31.013268.
    1. Baig A.M., Khaleeq A., Ali U., Syeda H. Evidence of the COVID-19 virus targeting the CNS: Tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem. Neurosci. 2020;11:995–998. doi: 10.1021/acschemneuro.0c00122.
    1. Yan R., Zhang Y., Li Y., Xia L., Guo Y., Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367:1444–1448. doi: 10.1126/science.abb2762.
    1. Holappa M., Vapaatalo H., Vaajanen A. Many faces of renin-angiotensin system-focus on eye. Open Ophthalmol. J. 2017;11:122. doi: 10.2174/1874364101711010122.
    1. Sungnak W., Huang N., Bécavin C., Berg M., Rachel Q., Litvinukova M., Talavera-López C., Maatz H., Reichart D., Sampaziotis F., et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat. Med. 2020 doi: 10.1038/s41591-020-0868-6.
    1. Napoli P.E., Nioi M., Mangoni L., Gentile P., Braghiroli M., d’Aloja E., Fossarello M. Fourier-Domain OCT Imaging of the Ocular Surface and Tear Film Dynamics: A Review of the State of the Art and an Integrative Model of the Tear Behavior During the Inter-Blink Period and Visual Fixation. J. Clin. Med. 2020;9:668. doi: 10.3390/jcm9030668.
    1. Sun Y., Liu L., Pan X., Jing M. Mechanism of the action between the SARS-CoV S240 protein and the ACE2 receptor in eyes. Int. J. Ophthalmol. 2006;6:783–786.
    1. Sun K., Gu L., Ma L., Duan Y. Atlas of ACE2 Gene Expression in Mammals Reveals Novel Insights in Transmission of SARS-Cov-2. BioRxiv. 1 January 2020. [(accessed on 26 April 2020)]; Available online: .
    1. Li Y.C., Bai W.Z., Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J. Med. Virol. 2020 doi: 10.1002/jmv.25824.
    1. Seah I., Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocular Immunol. Inflamm. 2020;28:391–395. doi: 10.1080/09273948.2020.1738501.
    1. Xia J., Tong J., Liu M., Shen Y., Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J. Med. Virol. 2020 doi: 10.1002/jmv.25725.
    1. Seah I.Y.J., Anderson D.E., Kang A.E.Z., Wang L., Rao P., Young B.E., Lye D.C., Agrawal R. Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients. Ophthalmology. 2020 doi: 10.1016/j.ophtha.2020.03.026.
    1. Leung N.H., Chu D.K., Shiu E.Y., Chan K.H., McDevitt J.J., Hau B.J., Yen H.L., Li Y., Ip D.K., Peiris J.M., et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat. Med. 2020 doi: 10.1038/s41591-020-0843-2.
    1. Asadi S., Bouvier N., Wexler A.S., Ristenpart W.D. The coronavirus pandemic and aerosols: Does COVID-19 transmit via expiratory particles? Aerosol. Sci. Technol. 2020:1–4. doi: 10.1080/02786826.2020.1749229.
    1. Guzman M. Bioaerosol Size Effect in COVID-19 Transmission. Preprints. 2020:2020040093. doi: 10.20944/preprints202004.0093.v1.
    1. Seah I., Su X., Lingam G. Revisiting the dangers of the coronavirus in the ophthalmology practice. Eye (Lond.) 2020 doi: 10.1038/s41433-020-0790-7.
    1. World Health Organization . Rational Use of Personal Protective Equipment for Coronavirus Disease (COVID-19) and Considerations during Severe Shortages: Interim Guidance, 6 April 2020. World Health Organization; Geneva, Switzerland: 2020. No. WHO/2019-nCov/IPC_PPE_use/2020.3.
    1. Chen X., Shang Y., Yao S., Liu R., Liu H. Perioperative care provider’s considerations in managing patients with the COVID-19 infections. Transl. Perioper Pain Med. 2020;15:216–224.
    1. Jones L., Walsh K., Willcox M., Morgan P., Nichols J. The COVID-19 pandemic: Important considerations for contact lens practitioners. Contact Lens Anterior Eye. 2020 doi: 10.1016/j.clae.2020.03.012.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel